newsfilter
← Latest News
GlobeNewswire·

Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties of Psilocin

Further strengthens the Company's drug development pipeline of tryptamines by introducing novel psilocin analogues containing enhancements in safety and efficacy tailored for medical use DENVER, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations